Food additives and "generally recognized as safe"

Food-additive law uses categories that are more specific than the everyday idea of an ingredient. A substance may be intentionally added for a particular use, yet follow a different legal pathway if qualified experts generally recognize that use under the relevant standard. The FDA explanation of generally recognized as safe, or GRAS places this distinction within federal food law. GRAS is a term describing a legal and evidentiary category; the phrase is not this reference's verdict about an ingredient or a recommendation about what to eat.

The food-additive category and its exceptions

The FDA explains that an intentionally added substance ordinarily falls within the food-additive definition and requires premarket review and approval, unless it qualifies for GRAS or another exclusion. The condition of use matters to that determination. The FDA GRAS page describes general recognition among qualified experts, not a rule that every quantity, manufacturing change or possible use of a substance receives the same treatment. Reading a regulatory description therefore requires attention to the substance's intended use, alongside the name of the ingredient.

Wikipedia's Federal Food, Drug, and Cosmetic Act article dates that law to 1938 and describes a food-additive definition that reaches substances becoming components of food directly or indirectly, or affecting food's characteristics. It describes exclusions within the legal definition. Ordinary language can call something an additive while the law assigns a particular use to an exception. Keeping the legal category separate from the everyday word avoids confusing an ingredient list with a regulatory determination.

The amendment and the Delaney clause

Wikipedia's Food Additives Amendment article explains that the 1958 amendment established the GRAS exemption and introduced testing requirements for new food additives. It also describes the Delaney clause, a prohibition concerning approval of additives found to induce cancer in humans or animals. This is the article's account of a legal test, rather than a statement that a particular food presents a health outcome. The clause belongs in the history of how the food-additive review framework was defined.

The same article describes difficulties in applying that prohibition as analytical methods detected smaller amounts. It explains that the legal rule did not distinguish among levels of carcinogenic potency or take account of actual risk in the same way as a quantitative assessment. The amendment reference also distinguishes food-additive provisions from later changes to pesticide-residue law. The pesticide-residue page covers the separate system of residue tolerances, rather than applying an ingredient-review description to all chemical questions.

What evidence the GRAS standard describes

For a scientific GRAS determination, FDA says the quantity and quality of evidence must match that required for food-additive approval. It describes generally available and accepted scientific information, ordinarily published, with unpublished material potentially providing corroboration. The agency explanation makes both evidence and general recognition part of the standard. Data supporting an intended use and recognition of those data by qualified experts are related requirements, but they are not identical descriptions of what has been established.

The FDA also describes a route based on experience from common food use before 1958 in its GRAS explanation. It says that this route requires a substantial history of consumption by a significant number of consumers. The historical-use route and the scientific-procedures route have different kinds of supporting information. Neither description, on its own, identifies every possible use of an ingredient as meeting the standard. The intended conditions remain part of the legal determination being described.

Notification and an agency response

Wikipedia's GRAS article distinguishes a determination made without FDA notification from one sent through the notification process. It describes possible responses in which FDA does not question the basis, finds the submitted information insufficient, or stops evaluation at the notifier's request. It also describes FDA affirmation through rulemaking. These are different procedural events, so language about notification or an agency response is more informative than an undifferentiated claim that an ingredient is approved.

The distinction is especially relevant to transparency. A determination made without notification does not pass through the same agency review described for a submitted notice. The GRAS reference summarizes concerns about oversight, documenting the basis for decisions, surveillance after marketing and the resources available for review. Critics' concerns are reported as concerns about the pathway. They do not, in this reference, become a claim that every ingredient following that pathway has the same outcome or evidentiary weakness.

The debate concerns the pathway as well as ingredients

The GRAS article reports calls for more transparency, more resources and mandatory premarket assessments. That account of the debate places those proposals alongside the distinction between voluntary notification and self-determination. These are arguments about what information an agency receives and how it uses its authority. The rulemaking page explains why a proposal for changing a review process, an adopted rule and a determination about a particular ingredient occupy different stages and categories.

Engineered-food consultation is another process

The FDA biotechnology explanation describes a voluntary plant-biotechnology consultation in which a developer supplies an assessment, FDA evaluates it, and consultation ends when the agency has no further questions. That is a description of a product-specific consultation process. It should be read alongside, rather than substituted for, the legal definitions governing ingredients. The engineered-food overview describes the shared agency system, while reading food-risk claims explains how comparisons, exposure estimates and uncertainty fit into assessments.